Literature DB >> 6969062

Congenital adrenal hyperplasia--a clinical and genetic survey. Are we detecting male salt-losers?

L Murtaza, J R Sibert, I Hughes, I C Balfour.   

Abstract

In a genetic and clinical study in Wales of congenital adrenal hyperplasia due to 21-hydroxylase deficiency, 26 cases were found in the period 1966 to 1977. No one was known to have died from the condition in the period. There were 14 female and 5 male salt-losers, and 5 female and 2 male nonsalt-losers. The discrepancy between the sexes suggests that some cases of congenital adrenal hyperplasia in males are not being detected. This is of concern as salt-losing cases may be dying without a diagnosis being established. The carrier incidence of the condition in females, assuming complete ascertainment, is 1:55. Salt-losers in Wales appear to be more than twice as common as nonsalt-losers. HLA typing of certain affected families confirmed a genetic linkage between the congenital adrenal hyperplasia gene and HLA. This linkage appears to exist in both forms of congenital adrenal hyperplasia and suggests that the genes for salt-losing and nonsalt-losing forms of congenital adrenal hyperplasia are alleles. The linkage between congenital adrenal hyperplasia and HLA provides a potential method for antenatal detection. However, only a few parents would wish to take advantage of this method if it were readily available.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6969062      PMCID: PMC1627026          DOI: 10.1136/adc.55.8.622

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  11 in total

1.  [On the genetics of the congenital adrenogenital syndrome (virilizing adrenal hyperplasia)].

Authors:  A PRADER; G J ANDERS; H HABICH
Journal:  Helv Paediatr Acta       Date:  1962

2.  Early diagnosis of salt-losing congenital adrenal hyperplasia in a newborn boy.

Authors:  I A Hughes; J S Winter
Journal:  Can Med Assoc J       Date:  1977-08-20       Impact factor: 8.262

3.  Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia.

Authors:  S Pang; J Hotchkiss; A L Drash; L S Levine; M I New
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

4.  An unusually high incidence of salt-losing congenital adrenal hyperplasia in the Alaskan Eskimo.

Authors:  A J Hirschfeld; J K Fleshman
Journal:  J Pediatr       Date:  1969-09       Impact factor: 4.406

5.  Early diagnosis of congenital adrenal hyperplasia.

Authors:  I A Hughes; D H Williams; A D Birch
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

6.  HLA and congenital adrenal hyperplasia linkage confirmed.

Authors: 
Journal:  Lancet       Date:  1978-04-29       Impact factor: 79.321

7.  The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.

Authors:  I A Hughes; J S Winter
Journal:  J Pediatr       Date:  1976-05       Impact factor: 4.406

8.  Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia.

Authors:  I A Hughes; A Wilton; C A Lole; O P Gray
Journal:  Arch Dis Child       Date:  1979-05       Impact factor: 3.791

9.  Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency).

Authors:  B Dupont; S E Oberfield; E M Smithwick; T D Lee; L S Levine
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

10.  Genetic variation in Wales.

Authors:  P S Harper
Journal:  J R Coll Physicians Lond       Date:  1976-07
View more
  6 in total

1.  Clinical aspects of congenital adrenal hyperplasia: early diagnosis and prognosis.

Authors:  I A Hughes
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Congenital adrenal hyperplasia in Birmingham: a retrospective analysis (1958-1985).

Authors:  N K Virdi; A Green
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

3.  HLA typing as a method of genetic counselling in congenital adrenal hyperplasia.

Authors:  M O Savage; H Field; E Wolf; M E Pembrey; D B Grant
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

4.  Value of selective screening for congenital adrenal hyperplasia in Hungary.

Authors:  J Sólyom; I A Hughes
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

5.  Prevalence of congenital adrenal hyperplasia in Kuwait.

Authors:  M M Lubani; A R Issa; R Bushnaq; Q A al-Saleh; K I Dudin; P C Reavey; M Y el-Khalifa; D S Manandhar; Y K Abdul Al; E A Ismail
Journal:  Eur J Pediatr       Date:  1990-03       Impact factor: 3.183

6.  Normal sex differences in prenatal growth and abnormal prenatal growth retardation associated with 46,XY disorders of sex development are absent in newborns with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Laura J Chalmers; Paul Doherty; Claude J Migeon; Kenneth C Copeland; Brianna C Bright; Amy B Wisniewski
Journal:  Biol Sex Differ       Date:  2011-05-05       Impact factor: 5.027

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.